Home » Authors » Holland Johnson

Articles by Holland Johnson

Studies add to the ongoing debate over DES performance

Sep. 1, 2005

By Holland Johnson

New HF guidelines emphasize early diagnosis and treatment

Aug. 25, 2005

By Holland Johnson

Deals roundup: Quest Diagnostics to acquire LabOne in $934M transaction

Aug. 11, 2005

By Holland Johnson

DES presentations lead late-breaking clinical trials sessions

Aug. 1, 2005

By Holland Johnson

Jarvik Heart gets FDA okay for pivotal trial of FlowMaker VAD

July 14, 2005

By Holland Johnson

SurModics’ implant tech trial marks a break from tradition

July 13, 2005

By Holland Johnson

Guidant reports progress is made in 2 key clinical trials

July 12, 2005

By Holland Johnson

Veteran medical device exec to leave Closure for start-up

July 7, 2005

By Holland Johnson

Three Guidant ICD recalls are given Class I status by FDA

July 6, 2005

By Holland Johnson

Docs offer differing views on stent use

July 1, 2005

By Holland Johnson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...